Fasudil attenuates lipopolysaccharide-induced acute lung injury in mice
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To investigate the protective effects of fasudil,a Rho kinase inhibitor,on the inflammation of lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice secondary to sepsis and its probably mechanism in mice. Methods:C57BL/6 mice were randomly assigned to the control group,the LPS group,the LPS+fasudil (10 mg/kg) group and the LPS+dexamethasone (Dex,5 mg/kg) group. Mortality rates of different timing of each group was assessed after the establishment of the model. Mice were sacrificed at 6 h after LPS injection. Serum,bronchoalveolar lavage fluid (BALF) and lung tissues were collected. ELISA was performed to analyze the level of TNF-α,IL-1β and IL-10 in the serum,analyze the cell count and the protein content in BALF,stain with hematoxylin and eosin;test the wet-to-dry (W/D) weight;measure the content of myeloperoxidase (MPO) content in lung tissue by ELISA. Results:Fasudil significantly improved the mortality rates and prolonged the survival time of mice,relieved inflammatory injury and edema of lung tissue,and decreased MPO content. Moreover,fasudil down regulated the expression of TNF-α and IL-1β and up regulated IL-10 in serum. Conclusion:Fasudil effectively relieved LPS-induced ALI,which may be relevant to controlling the inflammatory response in the lungs.

    Reference
    Related
    Cited by
Get Citation

Zhao Xinyun, Kong Hui, Wang Jingjing, Yan Xiaopei, Liu Wenrui, Zeng Xiaoning, Xie Weiping. Fasudil attenuates lipopolysaccharide-induced acute lung injury in mice[J].,2014,(7):898-903.

Copy
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:October 31,2013
  • Revised:
  • Adopted:
  • Online: July 05,2014
  • Published:
Article QR Code